TRIB News and Press, Trinity Biotech plc From 05/16/24

DUBLIN, Ireland, May 16, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced a strategic collaboration with medical artificial intelligen...

DUBLIN, Ireland, May 13, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced that it has received substantial additional orders for TrinS...

DUBLIN, Ireland, May 08, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced the appointment of Avinash Kale as Continuous Glucose Monito...

2024-04-30 18:00:47 ET More on Trinity Biotech Trinity Biotech plc (TRIB) Q4 2023 Earnings Call Transcript Trinity Biotech to implement ADS ratio change Financial information for Trinity Biotech Read the full article on Seeking Alpha For further detai...

2024-04-04 15:03:06 ET Trinity Biotech plc (TRIB) Q4 2023 Earnings Conference Call April 04, 2024 08:00 a.m. ET Company Participants John Gillard - Chief Executive Officer Des Fitzgerald - Chief Financial Officer Eric Ribner - Investor Relations Conference ...

DUBLIN, Ireland, April 04, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, today announced results for the quarter ended December 31, 2023 and fisca...

DUBLIN, Ireland, March 28, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, will report financial results for the fourth quarter and fiscal...

2024-03-08 11:45:29 ET More on Trinity Biotech Trinity Biotech to implement ADS ratio change Financial information for Trinity Biotech Read the full article on Seeking Alpha For further details see: Trinity Biotech regains compliance with Nasdaq minimum c...

2024-02-20 08:02:10 ET Trinity Biotech Plc (TRIB) announced stock split at a ratio of 1-for-5 on 2024-02-21 ... Full story available on KlickAnalytics.com

DUBLIN, Ireland, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc.(NASDAQ: TRIB) (the “Company”) today announced that it has finalized the effective date of its ratio change of its American depositary shares (“ADSs”) from one (1) ADS representing four (4) Class A ...